{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:21:23Z","timestamp":1791224483412,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.14310\/horm.2002.1376","type":"journal-article","created":{"date-parts":[[2014,1,31]],"date-time":"2014-01-31T23:02:35Z","timestamp":1391209355000},"page":"444-450","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Differences in plasma apelin and visfatin levels between patients with type 1 diabetes mellitus and healthy subjects and response after acute hyperglycemia and insulin administration"],"prefix":"10.1007","volume":"11","author":[{"given":"Kleopatra","family":"Alexiadou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Kokkinos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavros","family":"Liatis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Despoina","family":"Perrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Katsilambros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Tentolouris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,10,1]]},"reference":[{"key":"11040444_CR1","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1046\/j.1471-4159.2000.0740034.x","volume":"74","author":"DK Lee","year":"2000","unstructured":"Lee DK, Cheng R, Nguyen T, et al, 2000 Characterization of apelin, the ligand for the APJ receptor. J Neurochem 74: 34\u201341.","journal-title":"J Neurochem"},{"key":"11040444_CR2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0167-0115(01)00236-1","volume":"99","author":"K Tatemoto","year":"2001","unstructured":"Tatemoto K, Takayama K, Zou MX, et al, 2001 The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism. Regul Pept 99: 87\u201392.","journal-title":"Regul Pept"},{"key":"11040444_CR3","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.pharmthera.2005.04.001","volume":"107","author":"MJ Kleinz","year":"2005","unstructured":"Kleinz MJ, Davenport AP, 2005 Emerging roles of apelin in biology and medicine. Pharmacol Ther 107: 198\u2013211.","journal-title":"Pharmacol Ther"},{"key":"11040444_CR4","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1210\/en.2004-1427","volume":"146","author":"J Boucher","year":"2005","unstructured":"Boucher J, Masri B, Daviaud D, et al, 2005 Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology 146: 1764\u20131771.","journal-title":"Endocrinology"},{"key":"11040444_CR5","first-page":"RA112","volume":"12","author":"J Beltowski","year":"2006","unstructured":"Beltowski J, 2006 Apelin and visfatin: unique \u201cbeneficial\u201d adipokines upregulated in obesity? Med Sci Monit 12: RA112\u2013119.","journal-title":"Med Sci Monit"},{"key":"11040444_CR6","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1161\/01.RES.0000033522.37861.69","volume":"91","author":"I Szokodi","year":"2002","unstructured":"Szokodi I, Tavi P, F\u00f6ldes G, et al, 2002 Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility. Circ Res 91: 434\u2013440.","journal-title":"Circ Res"},{"key":"11040444_CR7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.cardiores.2004.08.018","volume":"65","author":"EA Ashley","year":"2005","unstructured":"Ashley EA, Powers J, Chen M, et al, 2005 The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo. Cardiovasc Res 65: 73\u201382.","journal-title":"Cardiovasc Res"},{"key":"11040444_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0304-3940(03)00351-3","volume":"353","author":"D Sunter","year":"2003","unstructured":"Sunter D, Hewson AK, Dickson SL, 2003 Intracerebroventricular injection of apelin-13 reduces food intake in the rat. Neurosci Lett 353: 1\u20134.","journal-title":"Neurosci Lett"},{"key":"11040444_CR9","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1080\/1028415031000111273","volume":"6","author":"M O\u2019Shea","year":"2003","unstructured":"O\u2019Shea M, Hansen MJ, Tatemoto K, Morris MJ, 2003 Inhibitory effect of apelin-12 on nocturnal food intake in the rat. Nutr Neurosci 6: 163\u2013167.","journal-title":"Nutr Neurosci"},{"key":"11040444_CR10","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.neuroscience.2004.08.007","volume":"129","author":"M J\u00e1szber\u00e9nyi","year":"2004","unstructured":"J\u00e1szber\u00e9nyi M, Bujdos\u00f3 E, Telegdy G, 2004 Behavioral, neuroendocrine and thermoregulatory actions of apelin-13. Neuroscience 129: 811\u2013816.","journal-title":"Neuroscience"},{"key":"11040444_CR11","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1006\/bbrc.2002.6575","volume":"291","author":"S Taheri","year":"2002","unstructured":"Taheri S, Murphy K, Cohen M, et al, 2002 The effects of centrally administered apelin-13 on food intake, water intake and pituitary hormone release in rats. Biochem Biophys Res Commun 291: 1208\u20131212.","journal-title":"Biochem Biophys Res Commun"},{"key":"11040444_CR12","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1046\/j.1471-4159.2001.00320.x","volume":"77","author":"A Reaux","year":"2001","unstructured":"Reaux A, De Mota N, Skultetyova I, et al, 2001 Physiological role of a novel neuropeptide, apelin, and its receptor in the rat brain. J Neurochem 77: 1085\u20131096.","journal-title":"J Neurochem"},{"key":"11040444_CR13","doi-asserted-by":"publisher","first-page":"4392","DOI":"10.1210\/en.2004-0384","volume":"145","author":"A Reaux-Le Goazigo","year":"2004","unstructured":"Reaux-Le Goazigo A, Morinville A, Burlet A, Llorens-Cortes C, Beaudet A, 2004 Dehydration-induced cross-regulation of apelin and vasopressin immunoreactivity levels in magnocellular hypothalamic neurons. Endocrinology 145: 4392\u20134400.","journal-title":"Endocrinology"},{"key":"11040444_CR14","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.bbrc.2004.10.042","volume":"325","author":"A Kasai","year":"2004","unstructured":"Kasai A, Shintani N, Oda M, et al, 2004 Apelin is a novel angiogenic factor in retinal endothelial cells. Biochem Biophys Res Commun 325: 395\u2013400.","journal-title":"Biochem Biophys Res Commun"},{"key":"11040444_CR15","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s10495-006-0489-7","volume":"12","author":"H Xie","year":"2007","unstructured":"Xie H, Yuan LQ, Luo XH, et al, 2007 Apelin suppresses apoptosis of human osteoblasts. Apoptosis 12: 247\u2013254.","journal-title":"Apoptosis"},{"key":"11040444_CR16","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1096\/fj.05-5243fje","volume":"20","author":"D Daviaud","year":"2006","unstructured":"Daviaud D, Boucher J, Gesta S, et al, 2006 TNFalpha up-regulates apelin expression in human and mouse adipose tissue. FASEB J 20: 1528\u20131530.","journal-title":"FASEB J"},{"key":"11040444_CR17","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1677\/JME-09-0071","volume":"44","author":"JE Brown","year":"2010","unstructured":"Brown JE, Onyango DJ, Ramanjaneya M, et al, 2010 Visfatin regulates insulin secretion, insulin receptor signalling and mRNA expression of diabetes-related genes in mouse pancreatic beta-cells. J Mol Endocrinol 44: 171\u2013178.","journal-title":"J Mol Endocrinol"},{"key":"11040444_CR18","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1515\/jpem.2010.081","volume":"23","author":"C Meral","year":"2010","unstructured":"Meral C, Tascilar E, Karademir F, et al, 2010 Elevated plasma levels of apelin in children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 23: 497\u2013502.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"11040444_CR19","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.diabres.2009.10.018","volume":"87","author":"B Telejko","year":"2010","unstructured":"Telejko B, Kuzmicki M, Wawrusiewicz-Kurylonek N, et al, 2010 Plasma apelin levels and apelin\/APJ mRNA expression in patients with gestational diabetes mellitus. Diabetes Res Clin Pract 87: 176\u2013183.","journal-title":"Diabetes Res Clin Pract"},{"key":"11040444_CR20","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1136\/bmj.300.6719.230","volume":"300","author":"JN Matthews","year":"1990","unstructured":"Matthews JN, Altman DG, Campbell MJ, Royston P, 1990 Analysis of serial measurements in medical research. BMJ 300: 230\u2013235.","journal-title":"BMJ"},{"key":"11040444_CR21","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1055\/s-2006-948309","volume":"114","author":"L Li","year":"2006","unstructured":"Li L, Yang G, Li Q, et al, 2006 Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects. Exp Clin Endocrinol Diabetes 114: 544\u2013548.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"11040444_CR22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.regpep.2005.05.003","volume":"130","author":"MV Heinonen","year":"2005","unstructured":"Heinonen MV, Purhonen AK, Miettinen P, et al, 2005 Apelin, orexin-A and leptin plasma levels in morbid obesity and effect of gastric banding. Regul Pept 130: 7\u201313.","journal-title":"Regul Pept"},{"key":"11040444_CR23","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1007\/s11695-009-9955-y","volume":"19","author":"F Soriguer","year":"2009","unstructured":"Soriguer F, Garrido-Sanchez L, Garcia-Serrano S, et al, 2009 Apelin levels are increased in morbidly obese subjects with type 2 diabetes mellitus. Obes Surg 19: 1574\u20131580.","journal-title":"Obes Surg"},{"key":"11040444_CR24","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1055\/s-2007-1004564","volume":"116","author":"G Erdem","year":"2008","unstructured":"Erdem G, Dogru T, Tasci I, Sonmez A, Tapan S, 2008 Low plasma apelin levels in newly diagnosed type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 116: 289\u2013292.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"11040444_CR25","doi-asserted-by":"publisher","first-page":"e150","DOI":"10.2337\/dc09-1146","volume":"32","author":"Y Zhang","year":"2009","unstructured":"Zhang Y, Shen C, Li X, et al, 2009 Low plasma apelin in newly diagnosed type 2 diabetes in Chinese people. Diabetes Care 32: e150.","journal-title":"Diabetes Care"},{"key":"11040444_CR26","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1210\/en.2006-1270","volume":"148","author":"K Higuchi","year":"2007","unstructured":"Higuchi K, Masaki T, Gotoh K, et al, 2007 Apelin, an APJ receptor ligand, regulates body adiposity and favors the messenger ribonucleic acid expression of uncoupling proteins in mice. Endocrinology 148: 2690\u20132697.","journal-title":"Endocrinology"},{"key":"11040444_CR27","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.cmet.2008.10.003","volume":"8","author":"C Dray","year":"2008","unstructured":"Dray C, Knauf C, Daviaud D, et al, 2008 Apelin stimulates glucose utilization in normal and obese insulin-resistant mice. Cell Metab 8: 437\u2013445.","journal-title":"Cell Metab"},{"key":"11040444_CR28","doi-asserted-by":"publisher","first-page":"E59","DOI":"10.1152\/ajpendo.00385.2009","volume":"298","author":"P Yue","year":"2010","unstructured":"Yue P, Jin H, Aillaud M, et al, 2010 Apelin is necessary for the maintenance of insulin sensitivity. Am J Physiol Endocrinol Metab 298: E59\u201367.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"11040444_CR29","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1530\/EJE-08-0039","volume":"158","author":"I Castan-Laurell","year":"2008","unstructured":"Castan-Laurell I, Vitkova M, Daviaud D, et al, 2008 Effect of hypocaloric diet-induced weight loss in obese women on plasma apelin and adipose tissue expression of apelin and APJ. Eur J Endocrinol 158: 905\u2013910.","journal-title":"Eur J Endocrinol"},{"key":"11040444_CR30","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.regpep.2005.05.004","volume":"131","author":"M S\u00f6rhede Winzell","year":"2005","unstructured":"S\u00f6rhede Winzell M, Magnusson C, Ahr\u00e9n B, 2005 The apj receptor is expressed in pancreatic islets and its ligand, apelin, inhibits insulin secretion in mice. Regul Pept 131: 12\u201317.","journal-title":"Regul Pept"},{"key":"11040444_CR31","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1210\/jc.2005-1475","volume":"91","author":"MP Chen","year":"2006","unstructured":"Chen MP, Chung FM, Chang DM, et al, 2006 Elevated plasma level of visfatin\/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 91: 295\u2013299.","journal-title":"J Clin Endocrinol Metab"},{"key":"11040444_CR32","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1210\/jc.2005-2248","volume":"91","author":"DG Haider","year":"2006","unstructured":"Haider DG, Schindler K, Schaller G, Prager G, Wolzt M, Ludvik B, 2006 Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding. J Clin Endocrinol Metab 91: 1578\u20131581.","journal-title":"J Clin Endocrinol Metab"},{"key":"11040444_CR33","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/j.1365-2362.2007.01904.x","volume":"38","author":"TD Filippatos","year":"2008","unstructured":"Filippatos TD, Derdemezis CS, Gazi IF, et al, 2008 Increased plasma visfatin levels in subjects with the metabolic syndrome. Eur J Clin Invest 38: 71\u201372.","journal-title":"Eur J Clin Invest"},{"key":"11040444_CR34","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.2337\/diabetes.54.10.2911","volume":"54","author":"J Berndt","year":"2005","unstructured":"Berndt J, Kl\u00f6ting N, Kralisch S, et al, 2005 Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes 54: 2911\u20132916.","journal-title":"Diabetes"},{"key":"11040444_CR35","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1210\/jc.2006-0361","volume":"91","author":"C Pagano","year":"2006","unstructured":"Pagano C, Pilon C, Olivieri M, et al, 2006 Reduced plasma visfatin\/pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans. J Clin Endocrinol Metab 91: 3165\u20133170.","journal-title":"J Clin Endocrinol Metab"},{"key":"11040444_CR36","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1111\/j.1365-2265.2007.02966.x","volume":"67","author":"K Oki","year":"2007","unstructured":"Oki K, Yamane K, Kamei N, Nojima H, Kohno N, 2007 Circulating visfatin level is correlated with inflammation, but not with insulin resistance. Clin Endocrinol (Oxf) 67: 796\u2013800.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"11040444_CR37","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.diabres.2006.07.031","volume":"76","author":"T Dogru","year":"2007","unstructured":"Dogru T, Sonmez A, Tasci I, et al, 2007 Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance. Diabetes Res Clin Pract 76: 24\u201329.","journal-title":"Diabetes Res Clin Pract"},{"key":"11040444_CR38","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1159\/000224338","volume":"72","author":"F Toruner","year":"2009","unstructured":"Toruner F, Altinova AE, Bukan N, et al, 2009 Plasma visfatin concentrations in subjects with type 1 diabetes mellitus. Horm Res 72: 33\u201337.","journal-title":"Horm Res"},{"key":"11040444_CR39","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.2337\/db06-0259","volume":"55","author":"A L\u00f3pez-Bermejo","year":"2006","unstructured":"L\u00f3pez-Bermejo A, Chico-Juli\u00e0 B, Fern\u00e0ndez-Balsells M, et al, 2006 Serum visfatin increases with progressive beta-cell deterioration. Diabetes 55: 2871\u20132875.","journal-title":"Diabetes"},{"key":"11040444_CR40","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.cmet.2007.09.003","volume":"6","author":"JR Revollo","year":"2007","unstructured":"Revollo JR, K\u00f6rner A, Mills KF, et al, 2007 Nampt\/PBEF\/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. Cell Metab 6: 363\u2013375.","journal-title":"Cell Metab"},{"key":"11040444_CR41","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1007\/s00125-006-0303-7","volume":"49","author":"DG Haider","year":"2006","unstructured":"Haider DG, Schaller G, Kapiotis S, Maier C, Luger A, Wolzt M, 2006 The release of the adipocytokine visfatin is regulated by glucose and insulin. Diabetologia 49: 1909.","journal-title":"Diabetologia"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.14310\/horm.2002.1376.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.14310\/horm.2002.1376\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.14310\/horm.2002.1376.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T15:37:08Z","timestamp":1739115428000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.14310\/horm.2002.1376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["11040444"],"URL":"https:\/\/doi.org\/10.14310\/horm.2002.1376","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10]]},"assertion":[{"value":"24 December 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}